Chronic Eczema
3
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Adherence To Topical Standard Therapy Assessed
Research Leaders
5 sponsors active, led by Bayer
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
67%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers
Revitalization of Damaged Skin Due to Chronic Skin Diseases
Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema
Research Network
Common Treatments
- Adherence To Topical Standard Therapy Assessed1
- Runzaozhiyang Capsule Agent Simulation1
- Urea1
- Runzao Zhiyang Capsule1
- Ace Csd1
Active Sponsors
- Bayer1
- Guizhou Tongjitang Pharmaceutical Co.,Ltd1
- Ace Cells Lab Limited1
- Jena University Hospital1
- Beijing Bionovo Medicine Development Co., Ltd.1
Top Investigators
Dermotology hospital, Chinese academy of medical science
ACE cells Lab europe DOO
University hospital Jena
Related Conditions
- Psoriasis1
- Adherence Patient1
- Atopic Dermatitis1